Synapse - Works

Results (6565)

Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer

Meeting Abstract

Traina, T. A.; Jones, L. W.; Blinder, V.; Scott, J.; Boyle, L. A.; Arumov, A.; Alano, T.; Patil, S.; DeFusco, P.; Lamparella, N.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Disease free survival rate with dose dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab (ddACTHP) in patients with HER2-positive early stage breast cancer: A single institution experience

Meeting Abstract

Singh, J. C.; Patil, S.; Norton, L.; Robson, M.; Dang, C.
Cancer Research (2020)

Fulltext@MSK | Save

In-breast pathologic complete response (pCR) following neoadjuvant chemotherapy predicts nodal pCR in early stage breast cancer

Meeting Abstract

Shamseddine, A.; Flynn, J.; Zhang, Z.; Morrow, M.; Mueller, B.; Gillespie, E.; Khan, A.; McCormick, B.; Cahlon, O.; Powell, S.; more...
Cancer Research (2020)

Fulltext@MSK | Save

A randomized phase 2 study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

Meeting Abstract

McArthur, H.; Comen, E.; Bryce, Y.; Solomon, S. B.; Leal, J.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D.; Norton, L.
Cancer Research (2020)

Fulltext@MSK | Save

Long-term outcomes and responses to retreatment in patients with melanoma treated with PD-1 blockade

Journal Article

Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K. S.; Hayes, S. A.; Bajwa, R.; Momtaz, P.; Callahan, M. K.; Wolchok, J. D.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA/PALB2 mutation